Background The sympathetic cotransmitter, neuropeptide Y (NPY), is released into the
coronary sinus during ST‐segment–elevation myocardial infarction and can constrict the …

Aims The co-transmitter neuropeptide-Y (NPY) is released during high sympathetic drive,
including ST-elevation myocardial infarction (STEMI), and can be a potent vasoconstrictor …

Objectives The co-transmitter neuropeptide Y (NPY) is released during high levels of
sympathetic stimulation and is a potent vasoconstrictor. We defined the release profile of …

Background Acute myocardial infarction is associated with the release of the co-transmitter
neuropeptide-Y (NPY). NPY acts as a potent vasoconstrictor and is associated with …

Aims ST-elevation myocardial infarction is associated with high levels of cardiac sympathetic
drive and release of the co-transmitter neuropeptide Y (NPY). We hypothesized that despite …

The sympathetic nervous system is activated in acute myocardial infarction (MI). Scarce data
exist, however, regarding the release of the sympathetic contrasmitter neuropeptide Y (NPY) …

Background—Neurohormones may influence vascular tone both during and after exercise.
Neuropeptide Y (NPY), which is costored and released with norepinephrine (NE) during …

In vivo studies have shown that sympathetic nerve stimulation improves the transmural
distribution of myocardial perfusion by increasing the endocardial/epicardial flow ratio; …

Pharmacologically induced angiogenesis could be a promising option in clinical situations
with diffuse inoperable coronary artery disease eg metabolic syndrome and diabetes …

Objectives. This study examined the coronary vasoconstrictive action of endogenous
neuropeptide Y (NPY) during sympathetic nerve stimulation and its modulation by the …